These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5558558)

  • 41. The HL-A system defined with lymphocytotoxic and platelet antibodies in relation to kidney transplantation.
    Kissmeyer-Nielsen F; Svejgaard A; Hauge M
    Transplant Proc; 1969 Mar; 1(1):357-61. PubMed ID: 4944239
    [No Abstract]   [Full Text] [Related]  

  • 42. Biological properties of antibody classes in transplantation immune sera.
    Voisin GA; Kinsky R; Jansen F; Bernard C
    Transplantation; 1969 Nov; 8(5):618-32. PubMed ID: 4994819
    [No Abstract]   [Full Text] [Related]  

  • 43. HL-A and ChL-A: similarities and differences.
    van Rood JJ; van Leeuwen A; Balner H
    Transplant Proc; 1972 Mar; 4(1):55-62. PubMed ID: 5011647
    [No Abstract]   [Full Text] [Related]  

  • 44. The interaction of normal lymphocytes and cells from lymphoid cell lines. VI. Line-directed cytotoxic specificity of lymphocytes activated by autochthonous or allogeneic LCL cells.
    Steel CM; Hardy DA; Ling NR; Lauder IJ
    Immunology; 1974 May; 26(5):1013-23. PubMed ID: 4854907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of four MLC-specificities in the dog.
    Grosse-Wilde H; Vriesendorp HM; Wank R; Mempel W; Dechamps B; Honauer U; Baumann P; Netzel B; Kolb HJ; Albert ED
    Tissue Antigens; 1974; 4(3):229-37. PubMed ID: 4277518
    [No Abstract]   [Full Text] [Related]  

  • 46. Joint report of 1st International Workshop on Canine Immunogenetics.
    Vriesendorp HM; Westbroek DL; D'Amaro J; van der Does JA; van der Steen GJ; van Rood JJ; Albert E; Bernini L; Bull RW; Cabasson J; Epstein RB; Erikson V; Feltkamp TE; Flad HD; Hammer C; Lang R; Largiadér F; von Loringhoven K; Los W; Meera Khan P; Saison R; Serrou B; Schnappauf H
    Tissue Antigens; 1973; 3(2):145-63. PubMed ID: 4274159
    [No Abstract]   [Full Text] [Related]  

  • 47. Cytotoxic lymphocytes. Mechanisms of activation and target-cell destruction.
    Perlmann P; Perlmann H
    Int Arch Allergy Appl Immunol; 1971; 41(1):36-9. PubMed ID: 5560978
    [No Abstract]   [Full Text] [Related]  

  • 48. Identification of further antigens on red cells and lymphocytes. Association of B g b with W17 (Te57) and B g e with W28 (Da15,Ba).
    Morton JA; Pickles MM; Sutton L; Skov F
    Vox Sang; 1971 Aug; 21(2):141-53. PubMed ID: 5120107
    [No Abstract]   [Full Text] [Related]  

  • 49. [Inhibitory effect on lymphocyte transformation of anti-HL-A sera].
    Pospísil M; Meo T; Carbonara AO; Ceppellini R
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(11):860-74. PubMed ID: 5524311
    [No Abstract]   [Full Text] [Related]  

  • 50. Histoincompatibility attributable to genes near H-2 that are not revealed by hemagglutination or cytotoxicity tests.
    Boyse EA; Flaherty L; Stockert E; Old LJ
    Transplantation; 1972 Apr; 13(4):431-2. PubMed ID: 4552366
    [No Abstract]   [Full Text] [Related]  

  • 51. Heterologous antisera for human histocompatibility testing.
    Balner H; Gabb BW; Dersjant H; Van Vreeswijk W; Van Leeuwen A; Van Rood JJ
    Transplant Proc; 1971 Jun; 3(2):1088-98. PubMed ID: 4944049
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunogenetic and biological aspects of in vitro lymphocyte allotransformation (MLR) in the mouse.
    Festenstein H
    Transplant Rev; 1973; 15():62-88. PubMed ID: 4130133
    [No Abstract]   [Full Text] [Related]  

  • 53. Histoincompatibilities found between congenic strains which differ at loci determing differentiation antigens.
    Flaherty L; Bennett D
    Transplantation; 1973 Nov; 16(5):505-14. PubMed ID: 4584957
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 55. [Anti HL-A transfusion immunization after extracorporeal circulation].
    Colombani J; Colombani M; Dastot H; Terrier E; Baillet M; Jaulmes B
    Nouv Rev Fr Hematol; 1972; 12(2):201-16. PubMed ID: 4264614
    [No Abstract]   [Full Text] [Related]  

  • 56. Serologic detection of lymphocyte cell-surface antigens controlled by the Ir region of the H-2 gene complex.
    David CS; Frelinger JA; Schreffler DC
    Transplant Proc; 1973 Dec; 5(4):1815-6. PubMed ID: 4544164
    [No Abstract]   [Full Text] [Related]  

  • 57. Antibody-mediated target cell lysis by non-immune cells. Characterization of the antibody and effector cell populations.
    Gelfand EW; Resch K; Prester M
    Eur J Immunol; 1972 Oct; 2(5):419-24. PubMed ID: 5084393
    [No Abstract]   [Full Text] [Related]  

  • 58. Genetics of the immune response in inbred and random bred mice against random copolymers of amino acids.
    Maurer PH; Merryman CF
    Ann Immunol (Paris); 1974 Jan; 125C(1-2):189-94. PubMed ID: 4142550
    [No Abstract]   [Full Text] [Related]  

  • 59. New lymphocyte antigens controlled by the Ir-IgG region of the H-2 gene complex.
    David CS; Frelinger JA; Shreffler DC
    Transplantation; 1974 Jan; 17(1):122-5. PubMed ID: 4543678
    [No Abstract]   [Full Text] [Related]  

  • 60. Preparation of monospecific HLA antibodies from cross-reactive multispecific antisera.
    Cross DE; Whittier FC; Greiner RF; Foxworth J; Weaver P; Ross JA
    Tissue Antigens; 1976 Aug; 8(2):101-8. PubMed ID: 968895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.